Andeksa (Azerbaijani Wikipedia)

Genmin Lu, Francis R. DeGuzman, Stanley J. Hollenbach, Mark J. Karbarz, Keith Abe. A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa // Nature Medicine . 19 (4). 2013-4. 446—451. doi:10.1038/nm.3102. ISSN 1546-170X. 2018-10-26 tarixində arxivləşdirilib.
Masahiro Yasaka. New Insights into Nonvitamin K Antagonist Oral Anticoagulants' Reversal of Intracerebral Hemorrhage // Frontiers of Neurology and Neuroscience . 37. 2015. 93—106. doi:10.1159/000437116. ISSN 1662-2804.
Young-A. Heo. Andexanet Alfa: First Global Approval // Drugs . 78 (10). 2018-7. 1049—1055. doi:10.1007/s40265-018-0940-4. ISSN 1179-1950.
Deborah Siegal, Genmin Lu, Janet M. Leeds, Mark Karbarz, Janice Castillo. Safety, pharmacokinetics, and reversal of apixaban anticoagulation with andexanet alfa // Blood Advances . 1 (ingilis) (21). 2017-09-26. 1827—1838. doi:10.1182/bloodadvances.2017007112. ISSN 2473-9537 2473-9529, 2473-9537 (#bad_issn).
Atanur Ersayin, Aline Thomas, Landry Seyve, Nicole Thielens, Mathieu Castellan. Catalytically inactive Gla-domainless factor Xa binds to TFPI and restores ex vivo coagulation in hemophilia plasma // Haematologica . 102 (12). 12 2017. e483—e485. doi:10.3324/haematol.2017.174037. ISSN 1592-8721.
Genmin Lu, Polly Pine, Janet M. Leeds, Francis DeGuzman, Pratikhya Pratikhya. Andexanet alfa effectively reverses edoxaban anticoagulation effects and associated bleeding in a rabbit acute hemorrhage model // PloS One . 13 (3). 2018. e0195122. doi:10.1371/journal.pone.0195122. ISSN 1932-6203.
Reversal agents for NOACs: Connecting the dots // Indian Heart Journal . 68 (ingilis) (4). 2016-07-01. 559—563. doi:10.1016/j.ihj.2015.11.023. ISSN 0019-4832.
Siegal, Deborah M.; Curnutte, John T.; Connolly, Stuart J.; Lu, Genmin; Conley, Pamela B.; Wiens, Brian L.; Mathur, Vandana S.; Castillo, Janice; Bronson, Michele D. Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity // [[|New England Journal of Medicine]] . 373 (ingilis). № 25. — 2015. — 17 dekabr. — 2413—2424. doi:10.1056/nejmoa1510991. ISSN 0028-4793. PMID 26559317.
Stuart J. Connolly, Truman J. Milling, John W. Eikelboom, C. Michael Gibson, John T. Curnutte. Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors // The New England journal of medicine . 375 (12). 2016-09-22. 1131—1141. doi:10.1056/NEJMoa1607887. ISSN 0028-4793.
Kalathottukaren, Manu T.; Creagh, A. Louise; Abbina, Srinivas; Lu, Genmin; Karbarz, Mark J.; Pandey, Anjali; Conley, Pamela B.; Kizhakkedathu, Jayachandran N.; Haynes, Charles. Comparison of reversal activity and mechanism of action of UHRA, andexanet, and PER977 on heparin and oral FXa inhibitors // Blood Advances . 2 (journal) (ingilis). № 16. — 2018. — 28 avqust. — 2104—2114. doi:10.1182/bloodadvances.2016003616. ISSN 2473-9537. PMID 30135185.
Dalal, Jamshed; Bhave, Abhay; Chaudhry, Gaurav; Rana, Prashant. Reversal agents for NOACs: Connecting the dots // Indian Heart Journal . 68 (journal) (ingilis). № 4. — 2016. — 1 iyul. — 559—563. doi:10.1016/j.ihj.2015.11.023. ISSN 0019-4832. PMID 27543482.

fda.gov (Global: 447^th place; Azerbaijani: 3,832^nd place)

"ANDEXXA (coagulation factor Xa (recombinant), inactivated-zhzo)". 8 sentyabr 2018 tarixində arxivləşdirilib. İstifadə tarixi: 25 oktyabr 2018.
"Andexxa package insert" (PDF). 26 iyul 2018 tarixində arxivləşdirilib (PDF). İstifadə tarixi: 25 oktyabr 2018.

medicalletter.org (Global: low place; Azerbaijani: low place)

secure.medicalletter.org

"Andexxa - An Antidote for Apixaban and Rivaroxaban". 26 oktyabr 2018 tarixində arxivləşdirilib. İstifadə tarixi: 25 oktyabr 2018.

nih.gov (Global: 4^th place; Azerbaijani: 17^th place)

ncbi.nlm.nih.gov

Genmin Lu, Francis R. DeGuzman, Stanley J. Hollenbach, Mark J. Karbarz, Keith Abe. A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa // Nature Medicine . 19 (4). 2013-4. 446—451. doi:10.1038/nm.3102. ISSN 1546-170X. 2018-10-26 tarixində arxivləşdirilib.
Masahiro Yasaka. New Insights into Nonvitamin K Antagonist Oral Anticoagulants' Reversal of Intracerebral Hemorrhage // Frontiers of Neurology and Neuroscience . 37. 2015. 93—106. doi:10.1159/000437116. ISSN 1662-2804.
Young-A. Heo. Andexanet Alfa: First Global Approval // Drugs . 78 (10). 2018-7. 1049—1055. doi:10.1007/s40265-018-0940-4. ISSN 1179-1950.
Atanur Ersayin, Aline Thomas, Landry Seyve, Nicole Thielens, Mathieu Castellan. Catalytically inactive Gla-domainless factor Xa binds to TFPI and restores ex vivo coagulation in hemophilia plasma // Haematologica . 102 (12). 12 2017. e483—e485. doi:10.3324/haematol.2017.174037. ISSN 1592-8721.
Genmin Lu, Polly Pine, Janet M. Leeds, Francis DeGuzman, Pratikhya Pratikhya. Andexanet alfa effectively reverses edoxaban anticoagulation effects and associated bleeding in a rabbit acute hemorrhage model // PloS One . 13 (3). 2018. e0195122. doi:10.1371/journal.pone.0195122. ISSN 1932-6203.
Siegal, Deborah M.; Curnutte, John T.; Connolly, Stuart J.; Lu, Genmin; Conley, Pamela B.; Wiens, Brian L.; Mathur, Vandana S.; Castillo, Janice; Bronson, Michele D. Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity // [[|New England Journal of Medicine]] . 373 (ingilis). № 25. — 2015. — 17 dekabr. — 2413—2424. doi:10.1056/nejmoa1510991. ISSN 0028-4793. PMID 26559317.
Stuart J. Connolly, Truman J. Milling, John W. Eikelboom, C. Michael Gibson, John T. Curnutte. Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors // The New England journal of medicine . 375 (12). 2016-09-22. 1131—1141. doi:10.1056/NEJMoa1607887. ISSN 0028-4793.
Kalathottukaren, Manu T.; Creagh, A. Louise; Abbina, Srinivas; Lu, Genmin; Karbarz, Mark J.; Pandey, Anjali; Conley, Pamela B.; Kizhakkedathu, Jayachandran N.; Haynes, Charles. Comparison of reversal activity and mechanism of action of UHRA, andexanet, and PER977 on heparin and oral FXa inhibitors // Blood Advances . 2 (journal) (ingilis). № 16. — 2018. — 28 avqust. — 2104—2114. doi:10.1182/bloodadvances.2016003616. ISSN 2473-9537. PMID 30135185.
Dalal, Jamshed; Bhave, Abhay; Chaudhry, Gaurav; Rana, Prashant. Reversal agents for NOACs: Connecting the dots // Indian Heart Journal . 68 (journal) (ingilis). № 4. — 2016. — 1 iyul. — 559—563. doi:10.1016/j.ihj.2015.11.023. ISSN 0019-4832. PMID 27543482.

pfizer.ru (Global: low place; Azerbaijani: low place)

"Пресс-релиз компании Pfizer". İstifadə tarixi: 25 oktyabr 2018.^{[ölü keçid]}

portola.com (Global: low place; Azerbaijani: low place)

investors.portola.com

"Пресс-релиз компании Portola pharmaceuticals". İstifadə tarixi: 25 oktyabr 2018.{{|date=Ноябрь 2019 |bot=InternetArchiveBot }}

sciencedirect.com (Global: 149^th place; Azerbaijani: 496^th place)

Reversal agents for NOACs: Connecting the dots // Indian Heart Journal . 68 (ingilis) (4). 2016-07-01. 559—563. doi:10.1016/j.ihj.2015.11.023. ISSN 0019-4832.
Dalal, Jamshed; Bhave, Abhay; Chaudhry, Gaurav; Rana, Prashant. Reversal agents for NOACs: Connecting the dots // Indian Heart Journal . 68 (journal) (ingilis). № 4. — 2016. — 1 iyul. — 559—563. doi:10.1016/j.ihj.2015.11.023. ISSN 0019-4832. PMID 27543482.

web.archive.org (Global: 1^st place; Azerbaijani: 1^st place)

Genmin Lu, Francis R. DeGuzman, Stanley J. Hollenbach, Mark J. Karbarz, Keith Abe. A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa // Nature Medicine . 19 (4). 2013-4. 446—451. doi:10.1038/nm.3102. ISSN 1546-170X. 2018-10-26 tarixində arxivləşdirilib.
"ANDEXXA (coagulation factor Xa (recombinant), inactivated-zhzo)". 8 sentyabr 2018 tarixində arxivləşdirilib. İstifadə tarixi: 25 oktyabr 2018.
"Andexxa package insert" (PDF). 26 iyul 2018 tarixində arxivləşdirilib (PDF). İstifadə tarixi: 25 oktyabr 2018.
"Andexxa - An Antidote for Apixaban and Rivaroxaban". 26 oktyabr 2018 tarixində arxivləşdirilib. İstifadə tarixi: 25 oktyabr 2018.

wikipedia.org (Global: low place; Azerbaijani: low place)

en.wikipedia.org

"Пресс-релиз компании Pfizer". İstifadə tarixi: 25 oktyabr 2018.^{[ölü keçid]}

worldcat.org (Global: 5^th place; Azerbaijani: 13^th place)

Genmin Lu, Francis R. DeGuzman, Stanley J. Hollenbach, Mark J. Karbarz, Keith Abe. A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa // Nature Medicine . 19 (4). 2013-4. 446—451. doi:10.1038/nm.3102. ISSN 1546-170X. 2018-10-26 tarixində arxivləşdirilib.
Masahiro Yasaka. New Insights into Nonvitamin K Antagonist Oral Anticoagulants' Reversal of Intracerebral Hemorrhage // Frontiers of Neurology and Neuroscience . 37. 2015. 93—106. doi:10.1159/000437116. ISSN 1662-2804.
Young-A. Heo. Andexanet Alfa: First Global Approval // Drugs . 78 (10). 2018-7. 1049—1055. doi:10.1007/s40265-018-0940-4. ISSN 1179-1950.
Deborah Siegal, Genmin Lu, Janet M. Leeds, Mark Karbarz, Janice Castillo. Safety, pharmacokinetics, and reversal of apixaban anticoagulation with andexanet alfa // Blood Advances . 1 (ingilis) (21). 2017-09-26. 1827—1838. doi:10.1182/bloodadvances.2017007112. ISSN 2473-9537 2473-9529, 2473-9537 (#bad_issn).
Atanur Ersayin, Aline Thomas, Landry Seyve, Nicole Thielens, Mathieu Castellan. Catalytically inactive Gla-domainless factor Xa binds to TFPI and restores ex vivo coagulation in hemophilia plasma // Haematologica . 102 (12). 12 2017. e483—e485. doi:10.3324/haematol.2017.174037. ISSN 1592-8721.
Genmin Lu, Polly Pine, Janet M. Leeds, Francis DeGuzman, Pratikhya Pratikhya. Andexanet alfa effectively reverses edoxaban anticoagulation effects and associated bleeding in a rabbit acute hemorrhage model // PloS One . 13 (3). 2018. e0195122. doi:10.1371/journal.pone.0195122. ISSN 1932-6203.
Mark Crowther, Genmin Lu, Janet M. Leeds, Joyce Lin, Pamela B. Conley. Reversal of Betrixaban-Induced Anticoagulation in Healthy Volunteers By Andexanet Alfa // {{|Blood (журнал)|Blood||Blood (journal)}} . 128 (ingilis) (22). {{|American Society of Hematology}}. 2016-12-02. 143—143. ISSN 1528-0020 0006-4971, 1528-0020 (#bad_issn).
Genmin Lu, Joyce Lin, John T. Curnutte, Pamela B. Conley. Reversal of Heparin-Induced Anticoagulation By Andexanet Alfa, a Universal Antidote for Factor Xa Inhibitors // {{|Blood (журнал)|Blood||Blood (journal)}} . 126 (ingilis) (23). {{|American Society of Hematology}}. 2015-12-03. 2329—2329. ISSN 1528-0020 0006-4971, 1528-0020 (#bad_issn).
Reversal agents for NOACs: Connecting the dots // Indian Heart Journal . 68 (ingilis) (4). 2016-07-01. 559—563. doi:10.1016/j.ihj.2015.11.023. ISSN 0019-4832.
Siegal, Deborah M.; Curnutte, John T.; Connolly, Stuart J.; Lu, Genmin; Conley, Pamela B.; Wiens, Brian L.; Mathur, Vandana S.; Castillo, Janice; Bronson, Michele D. Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity // [[|New England Journal of Medicine]] . 373 (ingilis). № 25. — 2015. — 17 dekabr. — 2413—2424. doi:10.1056/nejmoa1510991. ISSN 0028-4793. PMID 26559317.
Stuart J. Connolly, Truman J. Milling, John W. Eikelboom, C. Michael Gibson, John T. Curnutte. Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors // The New England journal of medicine . 375 (12). 2016-09-22. 1131—1141. doi:10.1056/NEJMoa1607887. ISSN 0028-4793.
Kalathottukaren, Manu T.; Creagh, A. Louise; Abbina, Srinivas; Lu, Genmin; Karbarz, Mark J.; Pandey, Anjali; Conley, Pamela B.; Kizhakkedathu, Jayachandran N.; Haynes, Charles. Comparison of reversal activity and mechanism of action of UHRA, andexanet, and PER977 on heparin and oral FXa inhibitors // Blood Advances . 2 (journal) (ingilis). № 16. — 2018. — 28 avqust. — 2104—2114. doi:10.1182/bloodadvances.2016003616. ISSN 2473-9537. PMID 30135185.
Dalal, Jamshed; Bhave, Abhay; Chaudhry, Gaurav; Rana, Prashant. Reversal agents for NOACs: Connecting the dots // Indian Heart Journal . 68 (journal) (ingilis). № 4. — 2016. — 1 iyul. — 559—563. doi:10.1016/j.ihj.2015.11.023. ISSN 0019-4832. PMID 27543482.

Andeksa (Azerbaijani Wikipedia)

bloodadvances.org (Global: low place; Azerbaijani: low place)

bloodjournal.org (Global: low place; Azerbaijani: low place)

doi.org (Global: 2nd place; Azerbaijani: 9th place)

fda.gov (Global: 447th place; Azerbaijani: 3,832nd place)

medicalletter.org (Global: low place; Azerbaijani: low place)

secure.medicalletter.org

nih.gov (Global: 4th place; Azerbaijani: 17th place)

ncbi.nlm.nih.gov

pfizer.ru (Global: low place; Azerbaijani: low place)

portola.com (Global: low place; Azerbaijani: low place)

investors.portola.com

sciencedirect.com (Global: 149th place; Azerbaijani: 496th place)

web.archive.org (Global: 1st place; Azerbaijani: 1st place)

wikipedia.org (Global: low place; Azerbaijani: low place)

en.wikipedia.org

worldcat.org (Global: 5th place; Azerbaijani: 13th place)

doi.org (Global: 2^nd place; Azerbaijani: 9^th place)

fda.gov (Global: 447^th place; Azerbaijani: 3,832^nd place)

nih.gov (Global: 4^th place; Azerbaijani: 17^th place)

sciencedirect.com (Global: 149^th place; Azerbaijani: 496^th place)

web.archive.org (Global: 1^st place; Azerbaijani: 1^st place)

worldcat.org (Global: 5^th place; Azerbaijani: 13^th place)